HCWB HCW Biologics Inc
Company Analysis
Latest News
🟢 HCW Biologics is trading 7.74% up today; catalyst remains unclear
HCW Biologics is trading 7.74% up at $2.71, rebounding from the August 17, 2026 close of $2.52 after several consecutive declines. - No new company-specific...
HCW Biologics Posts Widening Losses and Going-Concern Warning — Can This Biotech Survive Long Enough to Prove Its Science?
Shares of HCW Biologics plunged nearly 28% over the past week, falling from $3.17 to $2.28, after the clinical-stage biotech disclosed second-quarter results...
🔴 HCW Biologics is trading 9.69% down in pre-market after wider losses and going-concern doubt
HCW Biologics is trading 9.69% down at $2.28 after its August 14, 2026, second-quarter report highlighted a wider net loss and substantial doubt about...
🟢 HCW Biologics is trading 5.74% up in pre-market with no new company-specific announcement identified
HCW Biologics is trading at $2.66 (+5.74%) after closing at $2.52 on August 17, 2026; no new company-specific announcement was identified, and broader futures...
🔴 HCW Biologics is trading 5.78% down today after going-concern warning
HCW Biologics is trading 5.78% down now at $2.52 after investors continued reacting to the August 14, 2026 earnings release. - Second-quarter net loss widened...
HCW Biologics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 17, 2026
Wall Street analysts expect HCW Biologics to report a net loss of $1.98 per share for the second quarter of 2026, while the stock currently trades at...
HCW Biologics second quarter 2026 loss hit $5.2M despite $6.7M year-to-date licensing revenue
HCW Biologics reported second quarter 2026 revenue of $0.14 million and a net loss of $5.2 million. While year-to-date performance was bolstered by a...
HCW Biologics to Restate Q1 2026 Financials, Overstated EPS by $0.80
HCW Biologics announced that its previously issued financial statements for the first quarter ended March 31, 2026, should no longer be relied upon due to a...
🔴 HCW Biologics is trading 7.35% down today as the cause remains unclear
HCW Biologics is trading 7.35% down at $2.71, with no confirmed company-specific catalyst identified. - The stock declined from $2.92 on August 13, 2026. - No...
🟢 HCW Biologics is trading 6% up today with no confirmed catalyst
HCW Biologics is trading 5.98% up now at $3.10, with no confirmed company-specific catalyst identified for August 14, 2026. - The move follows a 7.00% decline...
🟢 HCW Biologics is trading 19.66% up in pre-market — no confirmed catalyst identified
HCW Biologics is trading 19.66% up at $3.50 in pre-market, with no confirmed company-specific catalyst identified for August 14. - The stock fell 7.00% to...
🔴 HCW Biologics is trading 7% down in pre-market with no confirmed overnight catalyst
HCW Biologics is trading at $2.72, down 7.01%, with no confirmed company-specific announcement or earnings release identified to explain the August 14...
🟢 HCW Biologics is trading 6% up in after-hours trading — no confirmed company-specific catalyst found
HCW Biologics is trading 5.98% up in after-hours trading at $3.10 after closing at $2.92 on August 13, 2026; no confirmed company-specific announcement or...
🟢 HCW Biologics is trading 7.26% up in after-hours trading with no clear company-specific catalyst identified
HCW Biologics is trading now 7.26% up at $3.40, with no clear company-specific catalyst identified for August 11, 2026. - The latest official company release...
🟢 HCW Biologics is trading 11% up in pre-market — no clear catalyst identified
HCW Biologics is trading 11.04% up at $3.63 in pre-market, with no clearly identified company-specific announcement on August 11, 2026. - Recent coverage...
🟢 HCW Biologics is trading 6% up in pre-market after insider-backed private placement
HCW Biologics is trading 5.57% up now at $3.60 in pre-market trading, as renewed attention to a July 29 private placement involving its CEO, board chairman,...
HCW Biologics CEO Buys Shares at $2.59 — Is This a Real Confidence Signal or a Tiny Bet on a Micro-Cap Gamble?
Shares of HCW Biologics surged as much as 8.1% to $3.61 on August 7, extending a sharp rally that began after CEO Hing Wong disclosed a personal stock purchase...
🔴 HCW Biologics is trading 5.98% down today after failing to extend its recent rally
HCW Biologics is trading 5.98% down at $3.23 after failing to extend its recent rally. - The stock declined from $3.60 on August 4 to $3.43 on August 5 and...
🟢 HCW Biologics is trading 7.6% up today as it rebounds from consolidation following an insider-fueled rally
HCW Biologics is trading at $3.69 (up 7.6%) in pre-market action, appearing to rebound within an ongoing momentum cycle following a period of consolidation. •...
🔴 HCW Biologics is trading 10.8% down today on profit-taking after an insider-driven rally
HCW Biologics is trading 10.8% down at $3.21 as the stock undergoes consolidation and profit-taking following a sharp multi-session rally. • The recent surge...